We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vectura Group Plc | LSE:VEC | London | Ordinary Share | GB00BKM2MW97 | ORD 0.0271P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 164.80 | 164.80 | 165.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/9/2017 08:02 | @justiceforthemany: The statement in the press release to does not suggest to me that there will be an approval of the generic Advair by the end of the year. "....Vectura expects to be able to confirm the regulatory timetable before the end of 2017...." This means they probably will only know by the end of the year when they will expect an approval (sometimes in 2018?). | 0815exitstrategy | |
06/9/2017 07:26 | A particular concern is the GSK litigation date. I thought that it was December this year but it is now December next year, a long time to have this hanging over the share price. | alexchry | |
06/9/2017 07:20 | The words said one thing and the figures said another. The best that can be said is that the business is going in the right direction (possibly). | pawdaw | |
06/9/2017 07:19 | The wider loss was due to a reduction in intangible assets of £50M. Shareholder equity still around £700M though with net cash stable down by only £2M at £90.5M | justiceforthemany | |
06/9/2017 07:16 | Others are not as positive as you are about results | andysaw | |
06/9/2017 07:09 | Buying op. If you're quick? | diesel | |
06/9/2017 07:08 | From a quick first glance, I don't see anything too bad in these results, at least nothing new which is bad. There's a lot of noise in them given the various one-off factors in each direction, plus the merger impacts plus and change in period end etc all of which combined make it messy to see performance compared to before and then project forwards. However all of that was expected. Need to do a much more detailed read but its not obvious to me that there's anything in those results which would make someone sell their shares today, which wasn't known yesterday | adamb1978 | |
06/9/2017 06:59 | The real gamechanger is Advair generic though and they seem confident of an FDA approval by the end of this year. | justiceforthemany | |
06/9/2017 06:58 | Loss due to write down of intangible assets, being The Skyepharma assets. This is like saying that they overpaid for these assets last year. However the business is creating cash and the sales are on the up. | jimboyce | |
06/9/2017 06:49 | Look at cash position, pretty static so operating loss is misleading. Recurring revenues are now getting quite substantial. | eastbourne1982 | |
06/9/2017 06:42 | Agree. Operating loss doubled | andysaw | |
06/9/2017 06:39 | That's a humdinger of a loss - didn't these guys get profitable prior to the merger? Thankfully got out last summer and they haven't rewarded anyone holding since | davr0s | |
06/9/2017 06:14 | The results don't look good IMO | andysaw | |
05/9/2017 13:25 | At this rate will be red by end of day | pooroldboy55 | |
05/9/2017 13:10 | Some progress on the litigation and FDA concerns about the Advair generic would steady the ship.Up early tomorrow! | fhmktg | |
05/9/2017 11:07 | I am hoping, too. But more important: Will the share price not fall back again, as it always did in the last months after the announcemnt of only positive financial results, as everbody seems to expect miracles to happen (GSK is going back to the old deal und the FDA approves tomorrow the Hikma product). | 0815exitstrategy | |
05/9/2017 09:52 | I'm expecting a nice rise tomorrow ,on the basis of growing royalties hopefully ahead of consensus. | best1467 | |
04/9/2017 07:51 | Uesally when I post a statement like that the share price has a good day!! | pooroldboy55 | |
04/9/2017 07:49 | All most 2 years of steady decline where will it end? Think if no good news on Wednesday will be under a pound seems nothing to stop it. | pooroldboy55 | |
03/9/2017 21:45 | Markets likely to be all over the place Monday because of North Korea uncertainty? | cap160 | |
02/9/2017 17:37 | I think both companies were vulnerable on their own, SKP primarily relying on Fluti, and VEC still waiting for a big cash earner, this does seem a more coherent set up just need to deliver on some of their strategy. Still holding some but thankfully sold a chunk over a year ago.... | diesel | |
31/8/2017 08:52 | 5845, Didn't skp 'mgt' (ahem) recommend this merger!!(FFS - the most obvious point). Every major strategic decision they have ever made never appeared to highlight to investors the true 'risks' involved which either means the PR is flawed or they weren't as aware as they should have been! However based upon director sales after merger I'd think 'different'. Mediocre at best! All imho. | dunderheed | |
31/8/2017 08:46 | I am not sure if only VEC is to blame here, they were also doing pretty good pre meger. SKP had also bad news post meger and it was the SKP finance chef who sold all his shares, something which was not very trust building. However the actual share price is still somewhat of a mystery to me. | 0815exitstrategy | |
31/8/2017 08:28 | Agree sold half of mine for av of 165p as in re transfer at 74p not to unhappy mind you i still have 40000 !!!!!!!!!!!!!!!!!! | pooroldboy55 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions